Medicare Enrolled

Dr. Barbara Gleeson, MSN, APN, C

Family Medicine · Pennsauken, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
6981 N PARK DR, Pennsauken, NJ 08109
8566634949
In practice since 2006 (20 years)
NPI: 1922087311 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gleeson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gleeson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gleeson

Dr. Barbara Gleeson is a family medicine specialist in Pennsauken, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gleeson performed 220 Medicare services across 152 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gleeson received a total of $4,710 from 31 pharmaceutical and/or device companies across 240 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gleeson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 220 Medicare services $4,710 industry payments

Medicare Practice Summary

Medicare Utilization ↗
220
Medicare services
Bottom 22% in NJ for family medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
152
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
122 $45 $284
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
57 $38 $200
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
21 $33 $53
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
20 $71 $140
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,710
Total received (2021-2024)
Avg $1,178/year across 4 years
Top 12% in NJ for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
240
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,710 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,973
2023
$1,428
2022
$799
2021
$511

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$535
Novo Nordisk Inc
$196
PFIZER INC.
$192
Lilly USA, LLC
$176
Boehringer Ingelheim Pharmaceuticals, Inc.
$163
Merck Sharp & Dohme LLC
$98
GlaxoSmithKline, LLC.
$90
Exact Sciences Corporation
$82
Astellas Pharma US Inc
$78
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$67
Novartis Pharmaceuticals Corporation
$62
ABBVIE INC.
$61
Kowa Pharmaceuticals America, Inc.
$48
Amgen Inc.
$47
Bayer Healthcare Pharmaceuticals Inc.
$38
Abbott Laboratories
$24
Phathom Pharmaceuticals, Inc.
$14
Top 3 companies account for 46.8% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$886
Merck Sharp & Dohme LLC
$533
Boehringer Ingelheim Pharmaceuticals, Inc.
$493
Novo Nordisk Inc
$340
Lilly USA, LLC
$289
GlaxoSmithKline, LLC.
$221
PFIZER INC.
$209
Biohaven Pharmaceuticals, Inc.
$173
Bayer Healthcare Pharmaceuticals Inc.
$148
Bayer HealthCare Pharmaceuticals Inc.
$148
Astellas Pharma US Inc
$123
ABBVIE INC.
$111
Amgen Inc.
$105
Abbott Laboratories
$96
SANOFI-AVENTIS U.S. LLC
$95
Novartis Pharmaceuticals Corporation
$91
Exact Sciences Corporation
$82
Biohaven Pharmaceutical Holding Company Ltd.
$71
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$67
E.R. Squibb & Sons, L.L.C.
$67
IDORSIA PHARMACEUTICALS US INC
$67
Otsuka America Pharmaceutical, Inc.
$63
Kowa Pharmaceuticals America, Inc.
$48
Xeris Pharmaceuticals, Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$32
Corium, LLC
$32
ARBOR PHARMACEUTICALS, INC.
$17
Boston Scientific Corporation
$16
Phathom Pharmaceuticals, Inc.
$14
SANOFI PASTEUR INC.
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 40.6% of all-time payments
Associated products mentioned in payments ›
ADLARITY · AIRSUPRA · AREXVY · BELSOMRA · BREZTRI · CAMZYOS · Cologuard Collection Kit · ELIQUIS · ENTRESTO · Edarbi · FARXIGA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · GVOKE HYPOPEN · GVOKE PFS · JARDIANCE · Kerendia · LEQVIO · MOUNJARO · Myrbetriq · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · TRADJENTA · TRINTELLIX · UBRELVY · VERQUVO · VOQUEZNA · Veozah · XIFAXAN · ZEPBOUND · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Pennsauken?
Compare family medicine physicians in the Pennsauken area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,305
Per 100K population
439.9
County median income
$86,384
Nearest hospital
COOPER UNIVERSITY HOSPITAL
3.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gleeson is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gleeson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gleeson performed 122 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gleeson receive payments from pharmaceutical companies?
Yes. Dr. Gleeson received a total of $4,710 from 31 companies across 240 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gleeson's costs compare to other family medicine physicians in Pennsauken?
Dr. Gleeson's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gleeson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →